du.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • chicago-author-date
  • chicago-note-bibliography
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry
Visa övriga samt affilieringar
Antal upphovsmän: 112018 (Engelska)Ingår i: CNS Neuroscience & Therapeutics, ISSN 1755-5930, E-ISSN 1755-5949, Vol. 24, nr 5, s. 439-447Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Aim

This 4‐week open‐label observational study describes the effect of introducing a microtablet dose dispenser and adjusting doses based on objective free‐living motor symptom monitoring in individuals with Parkinson's disease (PD).

Methods

Twenty‐eight outpatients with PD on stable levodopa treatment with dose intervals of ≤4 hour had their daytime doses of levodopa replaced with levodopa/carbidopa microtablets, 5/1.25 mg (LC‐5) delivered from a dose dispenser device with programmable reminders. After 2 weeks, doses were adjusted based on ambulatory accelerometry and clinical monitoring.

Results

Twenty‐four participants completed the study per protocol. The daily levodopa dose was increased by 15% (112 mg, < 0.001) from period 1 to 2, and the dose interval was reduced by 12% (22 minutes, P = 0.003). The treatment adherence to LC‐5 was high in both periods. The MDS‐UPDRS parts II and III, disease‐specific quality of life (PDQ‐8), wearing‐off symptoms (WOQ‐19), and nonmotor symptoms (NMS Quest) improved after dose titration, but the generic quality‐of‐life measure EQ‐5D‐5L did not. Blinded expert evaluation of accelerometry results demonstrated improvement in 60% of subjects and worsening in 25%.

Conclusions

The introduction of a levodopa microtablet dispenser and accelerometry aided dose adjustments improve PD symptoms and quality of life in the short term.

Ort, förlag, år, upplaga, sidor
2018. Vol. 24, nr 5, s. 439-447
Nyckelord [en]
Parkinson's disease; accelerometry; dose titration; microtablets; observational study
Nationell ämneskategori
Medicinteknik
Forskningsämne
Komplexa system - mikrodataanalys
Identifikatorer
URN: urn:nbn:se:du-27206DOI: 10.1111/cns.12807ISI: 000430058800008PubMedID: 29652438Scopus ID: 2-s2.0-85041030284OAI: oai:DiVA.org:du-27206DiVA, id: diva2:1182646
Tillgänglig från: 2018-02-14 Skapad: 2018-02-14 Senast uppdaterad: 2018-05-03Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Personposter BETA

Thomas, IliasWestin, Jerker

Sök vidare i DiVA

Av författaren/redaktören
Thomas, IliasWestin, Jerker
Av organisationen
MikrodataanalysDatateknik
I samma tidskrift
CNS Neuroscience & Therapeutics
Medicinteknik

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 61 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • chicago-author-date
  • chicago-note-bibliography
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf